Concepedia

Daniel Franco

DF

Statistics

Publications

17

Citations

665

H-Index

14

Active since

1996

Affiliations

Phoenix VA Health Care System(Current)

University of Arizona

Arizona State University

Midwestern University

University of Liverpool

Daniel Franco is an author at Phoenix VA Health Care System specializing in life sciences, endothelial dysfunction, and amyloid toxicity.

ORCID

Publications per year

1996–2025

17

Publications

17

Exenatide Protects Against Glucose- and Lipid-Induced Endothelial Dysfunction: Evidence for Direct Vasodilation Effect of GLP-1 Receptor Agonists in Humans

Juraj Koška, Michelle Sands, Camelia Burciu et al. · Diabetes · 2015 · 166 citations · Full text

, , +17

Human microvascular dysfunction and apoptotic injury induced by AL amyloidosis light chain proteins

Raymond Q. Migrino, Seth Truran, David D. Gutterman et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2011 · 85 citations

, , +15

Betulinic Acid-Mediated Apoptosis in Human Prostate Cancer Cells Involves p53 and Nuclear Factor-Kappa B (NF-κB) Pathways

Eswar Shankar, Ailin Zhang, Daniel Franco et al. · Molecules · 2017 · 75 citations · Full text

, , +17

Amyloidogenic medin induces endothelial dysfunction and vascular inflammation through the receptor for advanced glycation endproducts

Raymond Q. Migrino, Hannah A. Davies, Seth Truran et al. · Cardiovascular Research · 2017 · 49 citations · Full text

, , +16

Endothelial Immune Activation by Medin: Potential Role in Cerebrovascular Disease and Reversal by Monosialoganglioside‐Containing Nanoliposomes

Nina Karamanova, Seth Truran, Geidy E. Serrano et al. · Journal of the American Heart Association · 2020 · 39 citations · Full text

, , +14

1–5 of 17